Mozafar Mohammad, Shateri Kamran, Tabatabaey Ali, Lotfollahzadeh Saran, Atqiaee Khashayar
Department of General Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Internal Medicine Urmia University of Medical Sciences, Urmia, Iran.
Gastroenterol Hepatol Bed Bench. 2014 Fall;7(4):206-10.
In this study we describe the presentation, treatment, and complications of 27 FAP patients.
Treatment of Familial adenomatous polyposis (FAP) is centered on early recognition and curative surgery with either restorative proctocolectomy with ileal-pouch-anal-anastomosis (IPAA) or colectomy with ileo-rectal anastomosis (IRA).
All patients diagnosed with FAP at our center from 2008 to 2012 were included in this case series. Either IPAA or IRA was used for treatment. Complications were recorded for 12 months after the procedure.
Overall 27 patients were included, 12 (44.44%) index patients, and 15 (55.55%) relatives diagnosed by screening. Eight Index patients presented with rectal bleeding, two with occult fecal blood and two with abdominal masses found to be desmoid tumors. Nineteen patients were treated by IPAA, 6 with IRA, and 2 were inoperable due to diffuse desmoid tumors. Daytime stool frequency was the most common side effect (70.37%), followed by bowel discomfort episodes (55.56%), requiring dietary restrictions (37.4%), passive incontinence (25.93%), soiling (22.22%), nighttime stool frequency (18.52%), flatus incontinence (16.0%), and anastomosis leakage (3.70%). On average patients treated by IPAA experienced less complication than those treated by IRA.
compared with previous reports, this series had older age of diagnosis, higher rate of adenocarcinoma at diagnosis, and fewer side effects after IPAA than IRA. The latter may reflect technique improvement with experience, and if supported by future studies, will cement IPAA as the treatment of choice in FAP.
在本研究中,我们描述了27例家族性腺瘤性息肉病(FAP)患者的临床表现、治疗及并发症情况。
家族性腺瘤性息肉病(FAP)的治疗重点在于早期识别以及采用回肠袋肛管吻合术(IPAA)的根治性直肠结肠切除术或回肠直肠吻合术(IRA)进行手术治疗。
本病例系列纳入了2008年至2012年在我们中心诊断为FAP的所有患者。采用IPAA或IRA进行治疗。术后12个月记录并发症情况。
共纳入27例患者,其中12例(44.44%)为索引患者,15例(55.55%)为经筛查诊断出的亲属。8例索引患者出现直肠出血,2例出现粪便潜血,2例腹部肿块经检查为硬纤维瘤。19例患者接受了IPAA治疗,6例接受IRA治疗,2例因弥漫性硬纤维瘤无法手术。白天排便频率是最常见的副作用(70.37%),其次是肠道不适发作(55.56%),需要饮食限制(37.4%),被动性失禁(25.93%),污粪(22.22%),夜间排便频率(18.52%),排气失禁(16.0%)以及吻合口漏(3.70%)。平均而言,接受IPAA治疗的患者比接受IRA治疗的患者并发症更少。
与先前报告相比本系列患者诊断时年龄更大,诊断时腺癌发生率更高,且IPAA术后副作用比IRA少。后者可能反映了随着经验积累技术的改进,如果得到未来研究的支持,将巩固IPAA作为FAP首选治疗方法的地位。